CXBS (Corix Bioscience) Total Stockholders Equity: $3.56 Mil (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Corix Bioscience Total Stockholders Equity?

Corix Bioscience CXBS -99.00% Total Stockholders Equity is $3.56 Mil as of Sep. 2017.

Corix Bioscience's Total Stockholders Equity for the quarter that ended in Sep. 2017 was $3.56 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Corix Bioscience's Book Value per Share for the quarter that ended in Sep. 2017 was $0.17. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Corix Bioscience's Debt-to-Equity for the quarter that ended in Sep. 2017 was 0.01.

Corix Bioscience  (OTCPK:CXBS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Corix Bioscience's Book Value per Share for the quarter that ended in Sep. 2017 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(3.558-0)/20.653
=0.17

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Corix Bioscience's Debt-to-Equity for the quarter that ended in Sep. 2017 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.05 + 0) / 3.558
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience Total Stockholders Equity Related Terms

Corix Bioscience Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience Total Stockholders Equity Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Total Stockholders Equity
Get a 7-Day Free Trial -0.01 -0.02 -0.02 0.00 4.48

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.38 4.48 0.00 6.50 3.56
What does a Total Stockholders Equity of $3.56 Mil mean?
Corix Bioscience (CXBS) has a Total Stockholders Equity of $3.56 Mil as of Sep. 2017. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Corix Bioscience and its competitors.
Is Corix Bioscience's Total Stockholders Equity too high?
Corix Bioscience's current Total Stockholders Equity is $3.56 Mil.
How does Corix Bioscience's Total Stockholders Equity compare to BKIT and YBAO?
Corix Bioscience's Total Stockholders Equity of $3.56 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Corix Bioscience and its competitors. Corix Bioscience's current Total Stockholders Equity is $3.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current Total Stockholders Equity of $3.56 Mil. The current Total Stockholders Equity is $3.56 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current Total Stockholders Equity is $3.56 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.